ProFem GmbH: Clinical Trials

2 trials sponsored by ProFem GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 32Completed 1, Unknown 1

Follow ProFem GmbH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis
Phase 2 / Phase 3UnknownProFem GmbH4322019-10-012022-09-22
ProF-001_Phase IIa
Candiplus, Clotrimazole - Vulvovaginal Candidiasis (VVC)
Phase 2 / Phase 3CompletedProFem GmbH842017-04-042019-03-14

Conditions studied

Candidiasis, Vulvovaginal (2)  ·  Vulvovaginitis (1)

Interventions

Clotrimazole (1)  ·  Fluconazole (1)

Countries

Austria (2)  ·  Poland (1)  ·  Slovakia (1)

Top investigators

Herbert Kiss, Ao.Univ.Prof.Dr. (1)  ·  Herbert Kiss, Prof. (1)

Results publications

PMID 41845293